China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.
There’s no better time to register to attend the Health 2.0 Fall Conference, being held October 7-8 at the Hilton San Francisco.
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
Minnesota-based orthopedics startup Dgimed Ortho is seeking to raise $2 million for its bone-fracture system.
Breathing is one of the most basic human functions, but for an estimated 12 million people in the United States, the simple act of drawing a breath can be difficult and even painful.
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
If dementia care were a company, it would be the world’s largest in terms of annual revenue, surpassing even Wal-Mart.
One of the most anticipated medtech conferences happening this fall is the 2nd European Tech Tour MedTech Summit, to be held September 29-30, 2010 in Lausanne, Switzerland.
Recent news reports of young American athletes collapsing on the field have drawn media attention to sudden cardiac arrest, a leading cause of death in the U.S.
Copyright © 2026 | WordPress Theme by MH Themes